Amgen Appoints Lori Johnston As Senior Vice President, Human Resources

THOUSAND OAKS, Calif., Nov. 2, 2016 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the appointment of Lori Johnston to senior vice president, Human Resources, effective Dec. 9, 2016.

Johnston will be responsible for overseeing the global Human Resources function and report directly to Robert A. Bradway, chairman and chief executive officer.  

Johnston joins from the Celanese Corporation where she led the Human Resources function, most recently as executive vice president and chief administrative officer. Prior to joining Celanese, Lori spent over 10 years with Amgen in progressive leadership positions. Johnston also spent more than a decade with Dell Inc. in Human Resources and other business roles and also worked at the Michael and Susan Dell Foundation as head of Human Resources.

Bradway said, "We are pleased to have Lori Johnston return to lead Human Resources for Amgen. Her deep knowledge of Amgen, experience and strong leadership will be a key factor in ensuring Amgen's ability to compete intensely, deliver on our commitments and attract and retain world-class talent."

Johnston received a Master of Arts in Human Sciences from Our Lady of the Lake University in San Antonio, Texas and a Bachelor of Arts in Psychology from the University of Central Oklahoma in Edmond, Okla.

About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. 

For more information, visit and follow us on

CONTACT: Amgen, Thousand Oaks
Kristen Davis, 805-447-3008 (media)
Annie Kasparian, 805-447-1060 (investors)

 Amgen Logo.

Logo -


To view the original version on PR Newswire, visit: